查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
牙科软组织再生市场-全球和区域分析：按产品类型、应用、最终用户和区域-分析和预测（2025-2035年）
市场调查报告书
商品编码
1814818

牙科软组织再生市场-全球和区域分析：按产品类型、应用、最终用户和区域-分析和预测（2025-2035年）

Dental Soft-tissue Regeneration Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, Country, and Region- Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 100 Pages | 商品交期: 1-5个工作天内

价格

全球牙科软组织再生市场 - 分析与预测（2025-2035）

牙齿软组织再生是一种旨在修復和再生口腔内软组织（如牙龈、牙周膜和黏膜）的医疗过程。

这种再生治疗专注于促进因牙周病（牙周炎）、外伤或拔牙、植入等牙科手术后遗症而受损或流失的组织的自然癒合和再生。这个过程对于维持口腔的功能健康和美观至关重要。软组织再生在预防牙龈萎缩、支持植入以及恢復牙龈外观方面发挥重要作用。

牙齿软组织再生的治疗方法包括牙龈移植、富血小板血浆 (PRP) 和富血小板纤维蛋白 (PRF) 治疗、生物材料、雷射治疗以及正在进行的干细胞治疗研究。再生牙科领域在牙周病管理和植入治疗中正变得越来越重要，而健康强健的软组织对于牙科治疗的长期成功至关重要。

牙龈萎缩和牙周炎等牙周疾病的盛行率不断上升，是牙科软组织再生市场的主要驱动力之一。随着这些疾病在世界各地日益普遍，对能够再生受损牙周组织、恢復口腔健康并改善美观的有效治疗方法的需求也日益增长。牙周病影响相当一部分人口，通常会导致牙龈组织退化，如果不及时治疗，甚至会导致牙齿脱落。

解决这些问题的必要性，以及人们日益意识到保持牙龈健康对整体口腔健康的重要性，推动了软组织再生手术的需求。此外，人口老化和人工植牙治疗的兴起也进一步促进了这一增长，因为健康、再生的牙龈组织对于植入的成功和寿命至关重要。

儘管牙科软组织再生市场正在成长，但仍存在一些挑战。其中一个主要挑战是手术和材料的高成本。牙龈移植、富血小板血浆 (PRP) 疗法和先进生物材料等再生治疗通常成本高。

这些费用对于许多患者来说可能难以负担，尤其是那些保险有限或没有保险的患者。此外，手术的复杂性、专业培训的需求以及对高品质材料的需求也增加了整体费用，使得这些治疗难以被更广泛的患者群体所接受。这种经济障碍是阻碍软组织再生技术在牙科行业中应用和发展的主要障碍之一。

全球牙科软组织再生市场竞争激烈，许多主要企业引领着产业的成长与创新。登士柏西诺德 (Dentsply Sirona)、盖氏製药 (Geistlich Pharma AG)、士卓曼研究所 (Institut Straumann AG)、Tissue Regenix、Septodont Holding、Regedent AG、Advanced Medical Solutions Group PLC、Regenity、ZimVie Inc. 和亨利施恩 (Henry Schein, Inc.

这些公司正在大力投资研发，扩大产品系列，并建立策略伙伴关係关係，以提升竞争地位。他们专注于改进生物材料、再生技术和微创手术，以满足对有效软组织再生日益增长的需求。

这些公司提供种类繁多的尖端产品，满足牙科专业人士和患者的多样化需求，为市场发展做出了重要贡献。随着个人化、高效的软组织再生解决方案需求的不断增长，这些行业领导者将在塑造牙科行业的未来方面发挥关键作用。

牙科软组织再生市场细分

细分 1：依产品类型

  • 自体移植
  • 合成生物材料
  • 胶原胶原蛋白膜
  • 其他的

细分2：按应用

  • 植入
  • 牙周病
  • 其他的

细分 3：按最终用户

  • 牙科医院
  • DSO 和独立诊所
  • 学术和研究机构

细分4：按地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

全球牙科软组织再生市场最重要的新兴趋势之一是微创技术的日益普及。患者和牙科专业人士越来越青睐切口更小、恢復时间更短、不适感更少的治疗，这推动了对雷射治疗、果冻技术和基于生物材料的治疗的需求。

这些进步使得介入措施更加精准，减少了术后併发症，并提高了患者满意度。此外，富血小板血浆 (PRP)、富血小板纤维蛋白 (PRF) 和干细胞疗法等再生技术的应用也日益普及，因为它们具有加速癒合和组织再生的潜力。这种向微创再生治疗的转变显着提高了软组织再生在牙科领域，尤其是在牙周和植入治疗中的有效性和吸引力。

目录

执行摘要

第一章全球牙科软组织再生市场：产业展望

  • 介绍
  • 市场趋势
  • 法律规范
  • 专利分析
  • 案例研究
  • 产品基准
  • 市场动态

2. 全球牙科软组织再生市场（依产品类型），2024-2035

  • 自体移植
  • 合成生医材料
  • 胶原胶原蛋白膜
  • 其他的

3. 全球牙科软组织再生市场（按应用），2024-2035

  • 植入
  • 牙周病
  • 其他的

4. 2024-2035 年全球牙科软组织再生市场（依最终使用者划分）

  • 牙医诊所
  • DSO 和独立诊所
  • 学术研究机构

5. 2024-2035 年全球牙科软组织再生市场（按地区）

  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

6. 全球牙科软组织再生市场：竞争格局与公司简介

  • 关键策略和发展
  • 公司简介
    • Dentsply Sirona
    • Geistlich Pharma AG
    • Institut Straumann AG
    • Tissue Regenix
    • Septodont Holding
    • Regedent AG
    • Advanced Medical Solutions Group PLC
    • Regenity
    • ZimVie Inc.
    • Henry Schein, Inc.

第七章调查方法

Product Code: BHM3261SA

Global Dental Soft-tissue Regeneration Market, Analysis and Forecast: 2025-2035

Dental soft-tissue regeneration is a medical process aimed at restoring or regenerating the soft tissues in the oral cavity, such as the gums, periodontal ligaments, and mucous membranes.

This regenerative treatment focuses on promoting the natural healing and regeneration of tissues that have been damaged or lost due to conditions like gum disease (periodontitis), trauma, or following dental procedures such as tooth extractions or implants. The process is essential for maintaining the functional health and aesthetic appearance of the oral cavity. Soft-tissue regeneration plays a crucial role in preventing gum recession, supporting dental implant placement, and restoring the appearance of the gums, especially when there has been significant tissue loss.

Techniques used in dental soft-tissue regeneration include gum grafting, platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) treatments, biomaterials, laser therapy, and ongoing research into stem cell therapies. This area of regenerative dentistry is increasingly important in periodontal disease management and implantology, where healthy, robust soft tissue is crucial for the long-term success of dental treatments.

One of the primary drivers of the Dental Soft-Tissue Regeneration market is the rising prevalence of periodontal diseases, such as gum recession and periodontitis. As these conditions become more widespread globally, there is an increasing demand for effective treatments to regenerate lost gum tissue, restore oral health, and improve aesthetics. Periodontal disease, which affects a significant portion of the population, often leads to the deterioration of gum tissues and can result in tooth loss if left untreated.

The need to address these issues, coupled with the growing awareness of the importance of maintaining healthy gums for overall oral health, is fueling the demand for soft-tissue regeneration procedures. Additionally, the aging population and the rise in dental implant procedures further contribute to this growth, as healthy, regenerated gum tissue is essential for the success and longevity of implants.

Despite the growth of the Dental Soft-Tissue Regeneration market, several challenges persist. One of the primary challenges is the high cost of procedures and materials. Regenerative treatments, including gum grafting, platelet-rich plasma (PRP) therapies, and advanced biomaterials, often involve significant costs.

These costs can be prohibitive for many patients, especially when insurance coverage is limited or unavailable. Additionally, the complexity of the procedures, the need for specialized training, and the requirement for high-quality materials add to the overall expense, making these treatments less accessible to a broader patient base. This financial barrier remains one of the key obstacles to the widespread adoption and growth of soft-tissue regeneration techniques in the dental industry.

The global Dental Soft-Tissue Regeneration market is indeed highly competitive, with numerous prominent players shaping the industry's growth and innovation. Companies like Dentsply Sirona, Geistlich Pharma AG, Institut Straumann AG, Tissue Regenix, Septodont Holding, Regedent AG, Advanced Medical Solutions Group PLC, Regenity, ZimVie Inc., and Henry Schein, Inc. are driving the development of advanced solutions in soft-tissue regeneration.

These companies are investing heavily in research and development, expanding their product portfolios, and forming strategic partnerships to enhance their competitive edge. Their efforts are focused on improving biomaterials, regenerative technologies, and minimally invasive procedures to meet the growing demand for effective soft-tissue restoration.

By offering a wide range of cutting-edge products and addressing the diverse needs of dental professionals and patients, these companies are contributing significantly to the market's evolution. As the demand for personalized and effective soft-tissue regeneration solutions increases, these industry leaders are poised to play a critical role in shaping the future of dental care.

Dental Soft-tissue Regeneration Market Segmentation:

Segmentation 1: by Product Type

  • Autografts
  • Synthetic Biomaterials
  • Collagen-Based Membranes
  • Others

Segmentation 2: by Application

  • Implantology
  • Periodontology
  • Others

Segmentation 3: by End User

  • Dental Hospitals
  • DSO's & Independent Clinics
  • Academic & Research Institutions

Segmentation 4: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

One of the most significant emerging trends in the global Dental Soft-Tissue Regeneration market is the increasing adoption of minimally invasive techniques. Patients and dental professionals are increasingly favoring treatments that involve smaller incisions, shorter recovery times, and less discomfort, which is driving the demand for laser therapy, microsurgical techniques, and biomaterial-based treatments.

These advancements allow for more precise interventions, reduce post-operative complications, and improve patient satisfaction. Moreover, the use of regenerative technologies such as Platelet-Rich Plasma (PRP), Platelet-Rich Fibrin (PRF), and stem cell therapies is gaining traction, as they offer potential for accelerated healing and tissue regeneration. This shift towards minimally invasive and regenerative treatments is significantly enhancing the effectiveness and appeal of soft-tissue regeneration in dentistry, especially in periodontal care and implantology.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Dental Soft-tissue Regeneration Market: Industry Outlook

  • 1.1 Introduction
  • 1.2 Market Trends
  • 1.3 Regulatory Framework
  • 1.4 Patent Analysis
  • 1.5 Case Studies
  • 1.6 Product Benchmarking
  • 1.7 Market Dynamics
    • 1.7.1 Impact Analysis
    • 1.7.2 Market Drivers
    • 1.7.3 Market Challenges
    • 1.7.4 Market Opportunities

2. Global Dental Soft-tissue Regeneration Market (by Product Type), ($Billion), 2024-2035

  • 2.1 Autografts
  • 2.2 Synthetic Biomaterials
  • 2.3 Collagen-Based Membranes
  • 2.4 Others

3. Global Dental Soft-tissue Regeneration Market (by Application), ($Billion), 2024-2035

  • 3.1 Implantology
  • 3.2 Periodontology
  • 3.3 Others

4. Global Dental Soft-tissue Regeneration Market (by End User), ($Billion), 2024-2035

  • 4.1 Dental Hospitals
  • 4.2 DSO's & Independent Clinics
  • 4.3 Academic & Research Institutions

5. Global Dental Soft-tissue Regeneration Market (by Region), ($Billion), 2024-2035

  • 5.1 North America
    • 5.1.1 Key Findings
    • 5.1.2 Market Dynamics
    • 5.1.3 Market Sizing and Forecast
      • 5.1.3.1 North America Dental Soft-tissue Regeneration Market, by Country
        • 5.1.3.1.1 U.S.
        • 5.1.3.1.2 Canada
  • 5.2 Europe
    • 5.2.1 Key Findings
    • 5.2.2 Market Dynamics
    • 5.2.3 Market Sizing and Forecast
      • 5.2.3.1 Europe Dental Soft-tissue Regeneration Market, by Country
        • 5.2.3.1.1 Germany
        • 5.2.3.1.2 U.K.
        • 5.2.3.1.3 France
        • 5.2.3.1.4 Italy
        • 5.2.3.1.5 Spain
        • 5.2.3.1.6 Rest of the Europe
  • 5.3 Asia Pacific
    • 5.3.1 Key Findings
    • 5.3.2 Market Dynamics
    • 5.3.3 Market Sizing and Forecast
      • 5.3.3.1 Asia Pacific Dental Soft-tissue Regeneration Market, by Country
        • 5.3.3.1.1 China
        • 5.3.3.1.2 Japan
        • 5.3.3.1.3 India
        • 5.3.3.1.4 Australia
        • 5.3.3.1.5 Rest of Asia Pacific
  • 5.4 Rest of the World
    • 5.4.1 Key Findings
    • 5.4.2 Market Dynamics
    • 5.4.3 Market Sizing and Forecast

6. Global Dental Soft-tissue Regeneration Market: Competitive Landscape and Company Profiles

  • 6.1 Key Strategies and Development
    • 6.1.1 Mergers and Acquisitions
    • 6.1.2 Synergistic Activities
    • 6.1.3 Business Expansions and Funding
    • 6.1.4 Product Launches and Approvals
    • 6.1.5 Other Activities
  • 6.2 Company Profiles
    • 6.2.1 Dentsply Sirona
      • 6.2.1.1 Overview
      • 6.2.1.2 Top Products / Product Portfolio
      • 6.2.1.3 Top Competitors
      • 6.2.1.4 Target Customers/End-Users
      • 6.2.1.5 Key Personnel
      • 6.2.1.6 Analyst View
    • 6.2.2 Geistlich Pharma AG
      • 6.2.2.1 Overview
      • 6.2.2.2 Top Products / Product Portfolio
      • 6.2.2.3 Top Competitors
      • 6.2.2.4 Target Customers/End-Users
      • 6.2.2.5 Key Personnel
      • 6.2.2.6 Analyst View
    • 6.2.3 Institut Straumann AG
      • 6.2.3.1 Overview
      • 6.2.3.2 Top Products / Product Portfolio
      • 6.2.3.3 Top Competitors
      • 6.2.3.4 Target Customers/End-Users
      • 6.2.3.5 Key Personnel
      • 6.2.3.6 Analyst View
    • 6.2.4 Tissue Regenix
      • 6.2.4.1 Overview
      • 6.2.4.2 Top Products / Product Portfolio
      • 6.2.4.3 Top Competitors
      • 6.2.4.4 Target Customers/End-Users
      • 6.2.4.5 Key Personnel
      • 6.2.4.6 Analyst View
    • 6.2.5 Septodont Holding
      • 6.2.5.1 Overview
      • 6.2.5.2 Top Products / Product Portfolio
      • 6.2.5.3 Top Competitors
      • 6.2.5.4 Target Customers/End-Users
      • 6.2.5.5 Key Personnel
      • 6.2.5.6 Analyst View
    • 6.2.6 Regedent AG
      • 6.2.6.1 Overview
      • 6.2.6.2 Top Products / Product Portfolio
      • 6.2.6.3 Top Competitors
      • 6.2.6.4 Target Customers/End-Users
      • 6.2.6.5 Key Personnel
      • 6.2.6.6 Analyst View
    • 6.2.7 Advanced Medical Solutions Group PLC
      • 6.2.7.1 Overview
      • 6.2.7.2 Top Products / Product Portfolio
      • 6.2.7.3 Top Competitors
      • 6.2.7.4 Target Customers/End-Users
      • 6.2.7.5 Key Personnel
      • 6.2.7.6 Analyst View
    • 6.2.8 Regenity
      • 6.2.8.1 Overview
      • 6.2.8.2 Top Products / Product Portfolio
      • 6.2.8.3 Top Competitors
      • 6.2.8.4 Target Customers/End-Users
      • 6.2.8.5 Key Personnel
      • 6.2.8.6 Analyst View
    • 6.2.9 ZimVie Inc.
      • 6.2.9.1 Overview
      • 6.2.9.2 Top Products / Product Portfolio
      • 6.2.9.3 Top Competitors
      • 6.2.9.4 Target Customers/End-Users
      • 6.2.9.5 Key Personnel
      • 6.2.9.6 Analyst View
    • 6.2.10 Henry Schein, Inc.
      • 6.2.10.1 Overview
      • 6.2.10.2 Top Products / Product Portfolio
      • 6.2.10.3 Top Competitors
      • 6.2.10.4 Target Customers/End-Users
      • 6.2.10.5 Key Personnel
      • 6.2.10.6 Analyst View

7. Research Methodology

List of Figures

  • Figure: Global Dental Soft-tissue Regeneration Market (by Product Type), $Billion, 2024 and 2035
  • Figure: Global Dental Soft-tissue Regeneration Market (by Application), $Billion, 2024 and 2035
  • Figure: Global Dental Soft-tissue Regeneration Market (by End User), $Billion, 2024 and 2035
  • Figure: Global Dental Soft-tissue Regeneration Market (by Region), $Billion, 2024 and 2035
  • Figure: Global Dental Soft-tissue Regeneration Market Key Trends, Analysis

List of Tables

  • Table: Global Dental Soft-tissue Regeneration Market Dynamics, Impact Analysis
  • Table: Global Dental Soft-tissue Regeneration Market (by Region), $Billion, 2024-2035